Replies to post #811513 on NorthWest Biotherapeutics Inc (NWBO)

[learningcurve2020]

Without a productive Advent-Sawston that sounds about right.

[SkyLimit2022]

Nem,

Thanks for posting your free valuation analysis. Before we all recalibrate reality, what do you estimate the annual worldwide value of checkpoint inhibitors is? 😶



Fact ✅️:
Two of NWBO’s pipeline products are currently in clinical trials with Merck’s pembrolizumab, & Roswell partnered with NWBO for a licensing deal…

In addition to DCVax®-L at UCLA, Roswell’s aDC1platform has also reached Phase II in COMBO with commercial drugs (checkpoint inhibitors & TLR agonists).

For example, This Roswell PII clinical trial is active & posted an update on Dec 30th. Moffitt is included on its list of trial sites, & it’s funded by a peer-reviewed grant awarded by the 🇺🇸U.S. DoD:


ASCO 2025

Dr. Kalinski



⭐️Combo is King!⭐️

DCVax-L Combo PII UCLA

AI Fact-Checking